Elisaf MS - Search Results

1

Emerging drugs for hyperlipidaemia: an update.

Florentin M, Kostapanos MS, Kei A, Elisaf MS. Florentin M, et al. Among authors: elisaf ms. Expert Opin Emerg Drugs. 2014 Dec;19(4):471-88. doi: 10.1517/14728214.2014.976553. Epub 2014 Oct 30. Expert Opin Emerg Drugs. 2014. PMID: 25356785 Review.

2

The effect of fluvastatin on plasma fibrinogen levels.

Rizos E, Miltiadous G, Elisaf M. Rizos E, et al. Curr Med Res Opin. 2002;18(3):154-5. doi: 10.1185/030079902125000480. Curr Med Res Opin. 2002. PMID: 12094825

3

Effects of fibrates on serum metabolic parameters.

Elisaf M. Elisaf M. Curr Med Res Opin. 2002;18(5):269-76. doi: 10.1185/030079902125000516. Curr Med Res Opin. 2002. PMID: 12240789 Review.

4

The effects of lipid-regulating therapy on haemostatic parameters.

Milionis HJ, Elisaf MS, Mikhailidis DP. Milionis HJ, et al. Among authors: elisaf ms. Curr Pharm Des. 2003;9(29):2425-43. doi: 10.2174/1381612033453820. Curr Pharm Des. 2003. PMID: 14529557 Review.

5

Early vascular benefits of statin therapy.

Tsiara S, Elisaf M, Mikhailidis DP. Tsiara S, et al. Curr Med Res Opin. 2003;19(6):540-56. doi: 10.1185/030079903125002225. Curr Med Res Opin. 2003. PMID: 14594527 Review.

6

Effects of antihypertensive and hypolipidemic drugs on plasma and high-density lipoprotein-associated platelet activating factor-acetylhydrolase activity.

Tambaki AP, Rizos E, Tsimihodimos V, Tselepis AD, Elisaf M. Tambaki AP, et al. J Cardiovasc Pharmacol Ther. 2004 Jun;9(2):91-5. doi: 10.1177/107424840400900204. J Cardiovasc Pharmacol Ther. 2004. PMID: 15309245

7

Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia.

Milionis HJ, Kakafika AI, Tsouli SG, Athyros VG, Bairaktari ET, Seferiadis KI, Elisaf MS. Milionis HJ, et al. Among authors: elisaf ms. Am Heart J. 2004 Oct;148(4):635-40. doi: 10.1016/j.ahj.2004.04.005. Am Heart J. 2004. PMID: 15459594 Clinical Trial.

8

A review of the lipid-related effects of fluvastatin.

Liberopoulos EN, Daskalopoulou SS, Mikhailidis DP, Wierzbicki AS, Elisaf MS. Liberopoulos EN, et al. Among authors: elisaf ms. Curr Med Res Opin. 2005 Feb;21(2):231-44. doi: 10.1185/030079905x26261. Curr Med Res Opin. 2005. PMID: 15801994 Review.

9

Starting with rosuvastatin in primary hyperlipidemia--Is there more than lipid lowering?

Milionis HJ, Gazi IF, Filippatos TD, Tzovaras V, Chasiotis G, Goudevenos J, Seferiadis K, Elisaf MS. Milionis HJ, et al. Among authors: elisaf ms. Angiology. 2005 Sep-Oct;56(5):585-92. doi: 10.1177/000331970505600510. Angiology. 2005. PMID: 16193198 Clinical Trial.

10

Treating to target patients with primary hyperlipidaemia: comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study).

Milionis HJ, Rizos E, Kostapanos M, Filippatos TD, Gazi IF, Ganotakis ES, Goudevenos J, Mikhailidis DP, Elisaf MS. Milionis HJ, et al. Among authors: elisaf ms. Curr Med Res Opin. 2006 Jun;22(6):1123-31. doi: 10.1185/030079906X112462. Curr Med Res Opin. 2006. PMID: 16846545 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

527 results

Search Page